Zeo ScientifiX
Zeo ScientifiX, Inc.
Zeo ScientifiX, Inc., formerly known as Organicell Regenerative Medicine, Inc., is a publicly traded, clinical-stage biopharmaceutical company. It focuses on researching, developing, and manufacturing biological therapeutics derived from perinatal sources to treat degenerative diseases and support regenerative medicine applications.
Products & Team
Zofin
Zofin is the company's lead clinical candidate, an acellular biologic therapeutic formulated from perinatal sources. It is currently advancing through Phase I/II clinical trials for its potential to treat conditions such as COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis.
Zofin is being developed to address significant unmet medical needs in degenerative and inflammatory diseases by providing a novel therapeutic option.
Zeo ScientifiX addresses the need for effective treatments for degenerative conditions like COPD and osteoarthritis, advanced solutions for wound care and pain management, and innovative, science-backed products for aesthetic procedures and sexual health.